Quarterly Earnings

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

The environmental services giant surpassed 2025 targets, driven by its GreenUp strategy, major acquisitions in water tech, and a renewed global push.

After a year focused on organic growth, the environmental firm posted record results and now plans a disciplined return to acquisitions in 2026.

PROCEPT BioRobotics reports record Aquablation procedures but lowers 2026 revenue guidance, signaling a strategic shift for long-term profitability.

The biopharma company shatters records with 51% growth in its key drug, ASCENIV, and outlines a strategic overhaul aimed at long-term market dominance.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

FTAI Aviation reports a massive profit turnaround and raises its dividend, signaling confidence. But a pivot to power generation may be the real story.

Fintech giant Chime forecasts its first full year of GAAP profitability in 2026, propelled by its new ChimeCore platform, AI, and strong product growth.

The enterprise AI firm announced major layoffs after missing revenue targets, but points to strong government contract growth as a path to profitability.

With its CFO set to present, Commerce.com faces a key test: convincing investors its AI-driven ecosystem can outpace rivals and fuel future growth.

The well-funded mealtime innovator Wonder is betting big on Texas, promising thousands of jobs. But can its unique model conquer a crowded market?

The spirits giant faces a steep sales decline and a massive write-down, pivoting to premium brands and operational fixes amid an industry-wide hangover.

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

Legal tech firm DISCO reports strong growth fueled by a 600% surge in AI revenue, launching agentic AI and a disruptive new all-in-one pricing model.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.

While many cannabis firms struggle, Greenway Greenhouse reports a 40% revenue jump, expanding margins, and its fifth straight quarter of positive EBITDA.

As Kimco Realty prepares to present at the Raymond James conference, investors are watching for insights into its grocery-anchored retail strategy.

With $400M in 2025 sales, Immunocore now leverages its KIMMTRAK success to fund a high-stakes pivot into broader cancers, HIV, and autoimmune disease.

The cold storage giant saw strong cash flow growth in 2025 despite a net loss, but its conservative 2026 forecast signals persistent industry headwinds.